Medical Discovery Catapult: building leadership capability (2022)
Medicines Discovery Catapult (MDC) appointed Baxter Neumann in 2021 to help them strengthen their leadership team. Our work has resulted in two senior Executive appointments in 2022:
Chief Financial Officer, Sinéad McCormack and Robert Sherville-Payne
as General Counsel. MDC are reshaping the UK’s medicines discovery industry, driving the adoption of new technologies and innovation.
Share This Story, Choose Your Platform!